Gossamer Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.About GOSS
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions.
CEOFaheem Hasnain
CEOFaheem Hasnain
Employees145
Employees145
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees145
Employees145
GOSS Key Statistics
Market cap681.01M
Market cap681.01M
Price-Earnings ratio-4.89
Price-Earnings ratio-4.89
Dividend yield—
Dividend yield—
Average volume5.45M
Average volume5.45M
High today$3.37
High today$3.37
Low today$2.93
Low today$2.93
Open price$3.37
Open price$3.37
Volume4.80M
Volume4.80M
52 Week high$3.60
52 Week high$3.60
52 Week low$0.6617
52 Week low$0.6617
GOSS News
TipRanks 3d
Gossamer Bio’s Seralutinib: Promising Advancements in PAH Treatment Reinforce Buy RatingAnalyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Gossamer Bio and keeping the price target at $10.00. Elevate Your Investing Strategy: T...
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own GOSS. This list is generated using Robinhood data, and it’s not a recommendation.